Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Aortic Aneurysm, Thoracic | 6 | 2023 | 691 | 2.250 |
Why?
|
Myocardial Ischemia | 20 | 2023 | 2150 | 2.250 |
Why?
|
Stilbenes | 4 | 2015 | 157 | 1.430 |
Why?
|
Myocardium | 17 | 2023 | 4775 | 1.360 |
Why?
|
Calpain | 5 | 2023 | 150 | 0.890 |
Why?
|
Spinal Cord Injuries | 2 | 2021 | 931 | 0.890 |
Why?
|
Heptanoic Acids | 2 | 2014 | 343 | 0.860 |
Why?
|
Spinal Cord Ischemia | 1 | 2021 | 94 | 0.740 |
Why?
|
Heart Valve Prosthesis Implantation | 4 | 2023 | 1537 | 0.690 |
Why?
|
Endovascular Procedures | 3 | 2022 | 1980 | 0.680 |
Why?
|
Cardiotonic Agents | 4 | 2015 | 535 | 0.640 |
Why?
|
Aneurysm | 1 | 2021 | 339 | 0.630 |
Why?
|
Pyrroles | 2 | 2014 | 1147 | 0.620 |
Why?
|
Swine | 20 | 2023 | 5909 | 0.550 |
Why?
|
Autophagy | 2 | 2014 | 1296 | 0.540 |
Why?
|
Cardiopulmonary Bypass | 4 | 2015 | 1066 | 0.540 |
Why?
|
Collateral Circulation | 1 | 2015 | 287 | 0.480 |
Why?
|
Aortic Valve Stenosis | 5 | 2023 | 1955 | 0.430 |
Why?
|
Microvessels | 2 | 2015 | 544 | 0.410 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2021 | 1187 | 0.410 |
Why?
|
Protease Inhibitors | 1 | 2015 | 792 | 0.400 |
Why?
|
Ethanol | 5 | 2017 | 1343 | 0.400 |
Why?
|
Plant Extracts | 1 | 2015 | 471 | 0.390 |
Why?
|
Coronary Circulation | 3 | 2016 | 1572 | 0.390 |
Why?
|
Apoptosis | 8 | 2016 | 9718 | 0.370 |
Why?
|
Hypercholesterolemia | 3 | 2020 | 1151 | 0.370 |
Why?
|
Coronary Vessels | 4 | 2016 | 3106 | 0.370 |
Why?
|
Swine, Miniature | 8 | 2015 | 961 | 0.360 |
Why?
|
Cholesterol, Dietary | 3 | 2015 | 231 | 0.350 |
Why?
|
Signal Transduction | 12 | 2020 | 23398 | 0.350 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2014 | 3255 | 0.350 |
Why?
|
Splenic Artery | 1 | 2009 | 54 | 0.340 |
Why?
|
Neovascularization, Physiologic | 6 | 2016 | 1351 | 0.340 |
Why?
|
Glycoproteins | 4 | 2020 | 2266 | 0.340 |
Why?
|
Disease Models, Animal | 18 | 2023 | 18027 | 0.330 |
Why?
|
Heart | 3 | 2016 | 4460 | 0.300 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 3677 | 0.260 |
Why?
|
Coronary Artery Disease | 3 | 2021 | 6485 | 0.250 |
Why?
|
Aortic Valve | 6 | 2023 | 1920 | 0.230 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2014 | 3622 | 0.220 |
Why?
|
Spleen | 1 | 2009 | 2359 | 0.220 |
Why?
|
Wounds, Nonpenetrating | 1 | 2009 | 795 | 0.220 |
Why?
|
Heart Arrest, Induced | 2 | 2015 | 355 | 0.220 |
Why?
|
Spinal Cord | 2 | 2021 | 1809 | 0.220 |
Why?
|
Treatment Outcome | 14 | 2023 | 63042 | 0.210 |
Why?
|
Blood Vessel Prosthesis Implantation | 2 | 2022 | 1391 | 0.200 |
Why?
|
Gene Expression Profiling | 2 | 2015 | 9440 | 0.200 |
Why?
|
Pericardium | 2 | 2017 | 667 | 0.200 |
Why?
|
Insulin | 2 | 2013 | 6584 | 0.200 |
Why?
|
Heart Block | 1 | 2022 | 410 | 0.190 |
Why?
|
Angiogenic Proteins | 3 | 2015 | 104 | 0.190 |
Why?
|
Cognition Disorders | 1 | 2014 | 4041 | 0.180 |
Why?
|
Blotting, Western | 4 | 2015 | 5179 | 0.180 |
Why?
|
Stroke | 1 | 2022 | 9975 | 0.170 |
Why?
|
Embolization, Therapeutic | 1 | 2009 | 1392 | 0.170 |
Why?
|
Proteins | 1 | 2015 | 6098 | 0.170 |
Why?
|
Receptors, Notch | 2 | 2014 | 739 | 0.170 |
Why?
|
Prescriptions | 1 | 2021 | 387 | 0.170 |
Why?
|
Oxidative Stress | 4 | 2023 | 3082 | 0.170 |
Why?
|
Pyridones | 1 | 2023 | 711 | 0.160 |
Why?
|
Vascular System Injuries | 1 | 2022 | 250 | 0.160 |
Why?
|
Proteomics | 3 | 2016 | 3639 | 0.160 |
Why?
|
Group Processes | 1 | 2018 | 226 | 0.150 |
Why?
|
Thromboembolism | 1 | 2023 | 987 | 0.140 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2016 | 190 | 0.140 |
Why?
|
Animals | 23 | 2023 | 168660 | 0.140 |
Why?
|
Maleimides | 1 | 2016 | 112 | 0.140 |
Why?
|
Chronic Disease | 6 | 2016 | 9139 | 0.140 |
Why?
|
Sternotomy | 1 | 2017 | 121 | 0.140 |
Why?
|
Aortic Diseases | 1 | 2022 | 743 | 0.130 |
Why?
|
Alcoholic Beverages | 1 | 2017 | 265 | 0.130 |
Why?
|
Adherens Junctions | 1 | 2015 | 90 | 0.130 |
Why?
|
Warfarin | 1 | 2023 | 1497 | 0.120 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2014 | 2110 | 0.120 |
Why?
|
Vasodilation | 2 | 2015 | 944 | 0.120 |
Why?
|
Postoperative Complications | 5 | 2022 | 15281 | 0.120 |
Why?
|
Diabetic Cardiomyopathies | 1 | 2015 | 95 | 0.120 |
Why?
|
Income | 1 | 2023 | 1913 | 0.120 |
Why?
|
Lysosomal-Associated Membrane Protein 2 | 1 | 2013 | 52 | 0.120 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2013 | 104 | 0.120 |
Why?
|
bcl-2-Associated X Protein | 1 | 2014 | 295 | 0.110 |
Why?
|
Acute Disease | 2 | 2022 | 7150 | 0.110 |
Why?
|
Central Nervous System Depressants | 1 | 2014 | 167 | 0.110 |
Why?
|
Myocardial Perfusion Imaging | 2 | 2015 | 555 | 0.110 |
Why?
|
Heart Valve Diseases | 1 | 2021 | 1073 | 0.110 |
Why?
|
Pyrazoles | 1 | 2023 | 1970 | 0.110 |
Why?
|
Phytotherapy | 1 | 2015 | 298 | 0.110 |
Why?
|
Cardiomegaly | 1 | 2015 | 621 | 0.110 |
Why?
|
Ischemia | 1 | 2021 | 1907 | 0.110 |
Why?
|
Time Factors | 4 | 2022 | 40038 | 0.110 |
Why?
|
Cell Death | 2 | 2015 | 1705 | 0.110 |
Why?
|
Ventricular Remodeling | 1 | 2020 | 1225 | 0.110 |
Why?
|
Caspase 3 | 1 | 2014 | 758 | 0.110 |
Why?
|
Humans | 25 | 2023 | 743811 | 0.110 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2015 | 476 | 0.100 |
Why?
|
Coronary Artery Bypass | 1 | 2021 | 2288 | 0.100 |
Why?
|
Stents | 2 | 2022 | 3280 | 0.100 |
Why?
|
Male | 24 | 2022 | 349776 | 0.100 |
Why?
|
Forecasting | 1 | 2021 | 2950 | 0.100 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2014 | 1157 | 0.100 |
Why?
|
Vascular Surgical Procedures | 1 | 2020 | 1476 | 0.100 |
Why?
|
Collagen | 1 | 2020 | 2681 | 0.100 |
Why?
|
Alcohol Drinking | 2 | 2014 | 3965 | 0.100 |
Why?
|
Risk Factors | 6 | 2023 | 72252 | 0.100 |
Why?
|
STAT3 Transcription Factor | 1 | 2015 | 873 | 0.100 |
Why?
|
Microcirculation | 1 | 2015 | 1287 | 0.090 |
Why?
|
Retrospective Studies | 6 | 2023 | 77410 | 0.090 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2013 | 610 | 0.090 |
Why?
|
Phosphorylation | 3 | 2015 | 8436 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2013 | 1284 | 0.080 |
Why?
|
Microtubule-Associated Proteins | 1 | 2013 | 1083 | 0.080 |
Why?
|
Axotomy | 1 | 2007 | 73 | 0.080 |
Why?
|
Ganglia, Sympathetic | 1 | 2007 | 62 | 0.080 |
Why?
|
Indoles | 1 | 2016 | 1841 | 0.080 |
Why?
|
Healthcare Disparities | 1 | 2023 | 3155 | 0.080 |
Why?
|
MAP Kinase Signaling System | 1 | 2014 | 1524 | 0.070 |
Why?
|
United States | 4 | 2023 | 69859 | 0.070 |
Why?
|
Activating Transcription Factor 3 | 1 | 2007 | 54 | 0.070 |
Why?
|
General Surgery | 1 | 2018 | 1636 | 0.070 |
Why?
|
Metformin | 1 | 2014 | 837 | 0.070 |
Why?
|
Antioxidants | 1 | 2015 | 1658 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2015 | 3917 | 0.070 |
Why?
|
gamma Catenin | 2 | 2016 | 44 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2015 | 10940 | 0.070 |
Why?
|
Injury Severity Score | 1 | 2009 | 1014 | 0.070 |
Why?
|
Cardiac Surgical Procedures | 1 | 2021 | 3537 | 0.070 |
Why?
|
Diabetes Mellitus | 2 | 2015 | 5752 | 0.070 |
Why?
|
Myocytes, Cardiac | 1 | 2014 | 1631 | 0.060 |
Why?
|
Up-Regulation | 1 | 2013 | 4221 | 0.060 |
Why?
|
Neovascularization, Pathologic | 1 | 2014 | 2638 | 0.060 |
Why?
|
Protein Carbonylation | 1 | 2023 | 29 | 0.060 |
Why?
|
Coronary Angiography | 1 | 2015 | 4576 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7270 | 0.060 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2013 | 3510 | 0.050 |
Why?
|
Dietary Supplements | 1 | 2015 | 3292 | 0.050 |
Why?
|
Mitochondria | 1 | 2015 | 3513 | 0.050 |
Why?
|
DNA | 1 | 2015 | 7295 | 0.050 |
Why?
|
Cadherins | 2 | 2016 | 907 | 0.050 |
Why?
|
Adult | 3 | 2023 | 213889 | 0.050 |
Why?
|
Glucose | 1 | 2013 | 4398 | 0.050 |
Why?
|
Risk Assessment | 1 | 2022 | 23327 | 0.050 |
Why?
|
Marital Status | 1 | 2022 | 437 | 0.050 |
Why?
|
Algorithms | 1 | 2020 | 13869 | 0.040 |
Why?
|
STAT Transcription Factors | 1 | 2020 | 182 | 0.040 |
Why?
|
Hospitals, Community | 1 | 2021 | 347 | 0.040 |
Why?
|
Enzyme Activation | 2 | 2015 | 3701 | 0.040 |
Why?
|
Internship and Residency | 1 | 2018 | 5787 | 0.040 |
Why?
|
Disease Progression | 1 | 2014 | 13273 | 0.040 |
Why?
|
Chemokine CCL2 | 1 | 2020 | 620 | 0.040 |
Why?
|
Mitochondrial Proteins | 1 | 2023 | 993 | 0.040 |
Why?
|
Female | 10 | 2022 | 380020 | 0.040 |
Why?
|
Janus Kinase 2 | 1 | 2020 | 528 | 0.040 |
Why?
|
Atrial Fibrillation | 1 | 2015 | 5033 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2016 | 2504 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2023 | 2077 | 0.030 |
Why?
|
Tissue Adhesions | 1 | 2017 | 235 | 0.030 |
Why?
|
Sus scrofa | 1 | 2016 | 438 | 0.030 |
Why?
|
Aorta | 1 | 2022 | 2062 | 0.030 |
Why?
|
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 2013 | 68 | 0.030 |
Why?
|
In Situ Nick-End Labeling | 1 | 2015 | 644 | 0.030 |
Why?
|
Superoxide Dismutase | 1 | 2016 | 595 | 0.030 |
Why?
|
Cohort Studies | 2 | 2021 | 40545 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2016 | 552 | 0.030 |
Why?
|
Fibrosis | 1 | 2020 | 2030 | 0.030 |
Why?
|
Glucose Transporter Type 4 | 1 | 2013 | 250 | 0.030 |
Why?
|
Arterioles | 1 | 2013 | 254 | 0.030 |
Why?
|
Medicare | 2 | 2021 | 6565 | 0.030 |
Why?
|
Incidence | 2 | 2022 | 20948 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2021 | 4777 | 0.030 |
Why?
|
Endothelium, Vascular | 2 | 2015 | 4459 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2016 | 11360 | 0.030 |
Why?
|
Aged | 6 | 2021 | 163178 | 0.030 |
Why?
|
Capillary Permeability | 1 | 2015 | 798 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2022 | 6539 | 0.020 |
Why?
|
beta Catenin | 1 | 2016 | 1060 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2023 | 3660 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 623 | 0.020 |
Why?
|
Capillaries | 1 | 2013 | 773 | 0.020 |
Why?
|
Stroke Volume | 1 | 2023 | 5002 | 0.020 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 697 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39001 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2007 | 12066 | 0.020 |
Why?
|
Administration, Oral | 1 | 2017 | 3912 | 0.020 |
Why?
|
Species Specificity | 1 | 2013 | 2480 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2013 | 1081 | 0.020 |
Why?
|
Neurons | 1 | 2007 | 9336 | 0.020 |
Why?
|
Sympatholytics | 1 | 2007 | 83 | 0.020 |
Why?
|
Leukemia Inhibitory Factor | 1 | 2007 | 61 | 0.020 |
Why?
|
Anticoagulants | 1 | 2023 | 4599 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2016 | 1888 | 0.020 |
Why?
|
Length of Stay | 1 | 2021 | 6311 | 0.020 |
Why?
|
Oxidopamine | 1 | 2007 | 169 | 0.020 |
Why?
|
Patient Readmission | 1 | 2021 | 3117 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2013 | 15142 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2022 | 12354 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2013 | 1503 | 0.020 |
Why?
|
Forkhead Transcription Factors | 1 | 2014 | 1613 | 0.020 |
Why?
|
Nerve Growth Factor | 1 | 2007 | 148 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2013 | 1678 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2021 | 57744 | 0.020 |
Why?
|
Antigens, CD | 1 | 2015 | 4026 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15067 | 0.020 |
Why?
|
Cell Survival | 1 | 2014 | 5881 | 0.010 |
Why?
|
Middle Aged | 4 | 2021 | 213241 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2014 | 2877 | 0.010 |
Why?
|
Cytokines | 1 | 2016 | 7324 | 0.010 |
Why?
|
Quality of Life | 1 | 2021 | 12788 | 0.010 |
Why?
|
Antibodies | 1 | 2007 | 2459 | 0.010 |
Why?
|
Blood Glucose | 1 | 2013 | 6259 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2013 | 7880 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2007 | 8300 | 0.010 |
Why?
|
Inflammation | 1 | 2015 | 10629 | 0.010 |
Why?
|
Rats | 1 | 2007 | 24250 | 0.010 |
Why?
|
Prospective Studies | 1 | 2015 | 53250 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2007 | 21824 | 0.010 |
Why?
|
Mice | 1 | 2007 | 81154 | 0.000 |
Why?
|